Walvax Biotechnology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wei Yao
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
CEO
Wei Yao (52 yo)
less than a year
Tenure
CN¥1,831,600
Compensation
Mr. Wei Yao is President of Walvax Biotechnology Co. Ltd. from 2024. Mr. Yao was Marketing Director of Walvax Biotechnology Co. Ltd.from August 12, 2016 to 2024.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.83m | no data | |
| Vice Chairman & VP | 3.3yrs | CN¥2.05m | no data | |
| Chief Financial Officer | less than a year | CN¥313.20k | no data | |
| Director of Operations | 7.6yrs | CN¥1.10m | 0.042% CN¥ 6.9m | |
| Board Secretary | 2.6yrs | CN¥1.07m | no data | |
| Engineering Director | 1.8yrs | CN¥1.11m | no data |
1.8yrs
Average Tenure
42yo
Average Age
Experienced Management: 300142's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.83m | no data | |
| Vice Chairman & VP | 3.3yrs | CN¥2.05m | no data | |
| Chairman | 15.9yrs | CN¥2.84m | 1.7% CN¥ 278.3m | |
| Vice Chairman | 8yrs | CN¥3.53m | 1.11% CN¥ 181.4m | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Chairwoman of the Supervisory Board | 4.8yrs | no data | no data | |
| Non-Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Director | 3.5yrs | CN¥234.00k | 0.0044% CN¥ 718.0k | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Employee Supervisor | 2.6yrs | no data | no data |
3.4yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 300142's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/13 05:18 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Walvax Biotechnology Co., Ltd. is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Tong Zhang | China Merchants Securities Co. Ltd. |
| Ling Bo Tu | China Minzu Securities |